Izzy Wood (Drug Target Review)2023-01-20T09:42:18
US researchers outline the development of a new system for testing and developing CRISPR-based gene drives in the laboratory, and safely converting them into tools for potential real-world applications.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-03-07T10:55:58
Sponsored by Agilent
2023-03-30T12:35:58
Sponsored by Sartorius
2023-04-04T15:03:09
Sponsored by Agilent
2026-05-05T13:24:00
Sponsored by HUB Organoids
Site powered by Webvision Cloud